|
|
Volumn 1, Issue 2, 2001, Pages 171-176
|
|
Determination of the falloff constant “k“f”” from modeling biochemical marker release: A new variable for discriminating therapies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
CARDIOVASCULAR AGENT;
CREATINE KINASE;
CREATINE KINASE MB;
FIBRINOGEN RECEPTOR;
ISOENZYME;
ALGORITHM;
ARTICLE;
BIOASSAY;
BIOLOGICAL MODEL;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG ANTAGONISM;
HUMAN;
PROGNOSIS;
PSYCHOLOGICAL ASPECT;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
ALGORITHMS;
BIOLOGICAL MARKERS;
CARDIOVASCULAR AGENTS;
CLINICAL TRIALS;
CORONARY DISEASE;
CREATINE KINASE;
CREATINE KINASE, MB FORM;
DATA INTERPRETATION, STATISTICAL;
ENDPOINT DETERMINATION;
HUMANS;
ISOENZYMES;
MODELS, BIOLOGICAL;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PROGNOSIS;
TREATMENT OUTCOME;
|
|
EID: 0035756726
PISSN: 15307905
EISSN: None
Source Type: Journal
DOI: 10.1385/CT:1:2:171 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|